• LinkedIn
  • Twitter
Vesigen Therapeutics
  • About
    • Company Overview
    • Team
    • Investors
    • News
  • Science/Technology
  • Programs
  • Careers
  • Contact
  • Menu Menu
  • About
    • Company Overview
    • Team
    • Investors
    • News
  • Science/Technology
  • Programs
  • Careers
  • Contact

News

Stay updated on Vesigen innovations

Press Release

Vesigen Therapeutics launches with USD 28.5 million Series A investment led by Leaps by Bayer and Morningside Ventures

Vesigen Therapeutics launches with USD 28.5 million Series A investment led by Leaps by Bayer and Morningside Ventures Vesigen Therapeutics ...
Publication

Formation and release of arrestin domain-containing protein 1-mediated microvesicles (ARMMs) at plasma membrane by recruitment of TSG101 protein

Nabhan, J., et al., Proceedings of the National Academy of Sciences (2012) ...
Publication

Plasma membrane-derived extracellular microvesicles mediate non-canonical intracellular NOTCH signaling

Wang, Q., Lu, Q., Nat Commun 8, 709 (2017) ...
Publication

ARMMs as a versatile platform for intracellular delivery of macromolecules

Wang, Q., Yu, J., Kadungure, T. et al., Nat Commun 9, 960 (2018) ...
Loading...

Stay Connected

  • About
  • Science/Technology
  • Programs
  • Careers
  • Contact

Vesigen Therapeutics
790 Memorial Drive
Suite 103
Cambridge, MA 02139

LinkeInTwitter

© 2020 Vesigen Therapeutics
All rights reserved.
Privacy Policy
Terms of Use

Design and development by RainCastle Communications
Scroll to top
  • About
    • Company Overview
    • Team
    • Investors
    • News
  • Science/Technology
  • Programs
  • Careers
  • Contact